Leah Li has a diverse work experience in the biotechnology and pharmaceutical industries. Leah is currently working as a Solution BD Manager at GenScript ProBio since March 2023. Previously, they held the position of Senior Business Executive at Atlantis Bioscience Pte Ltd from December 2022 to March 2023. Prior to that, they served as an Overseas BD representative at GemPharmatech until December 2022. Leah also has experience as an R&D Project Manager at Nanjing YunQiao Biotechnology CO.,Ltd. from September 2018 to May 2019, and as a Pharmaceutical analyst at Jiangsu Provincial People's Hospital from January 2018 to July 2018.
Leah Li's education history begins in 2014 when they attended China Pharmaceutical University, where they pursued a Bachelor of Pharmacy degree in Pharmacology. Leah completed their undergraduate studies in 2018. In the same year, they briefly enrolled at The University of British Columbia to further their knowledge in Pharmacology, although their degree status is unspecified.
Leah's educational journey continued in 2020 when they joined the University of Windsor. There, they focused on Biotechnology and pursued a Master of Medical Biotechnology degree. Leah completed their studies in 2021.
In summary, Leah Li completed their Bachelor's degree in Pharmacology at China Pharmaceutical University from 2014 to 2018. Leah then briefly attended The University of British Columbia in 2018. Later, they pursued their Master's degree in Medical Biotechnology at the University of Windsor from 2020 to 2021.
This person is not in any offices